Prediabetes and cancer
Prediabetes is defined as a fasting blood sugar between 100-124 and a new study from China found that it might also be associated with a 15% increase in cancer (independent of obesity-itself a major risk factor for cancer). One diabetes medication that we have used for years, METFORMIN (used both to treat both prediabetes and diabetes) has been shown to decrease cancer by 30% in diabetics but has never been proven to do so scientifically in prediabetes or in otherwise healthy patients.
The authors of this study suggest that metformin may be considered in any patient who has a high risk for getting cancer. Please note, that while metformin is cheap and safe, is not FDA approved for this indication.
Maybe it’s time for more studies.